AzTrials
AzTrials

Heart FailureHEROICNCT03963583

Heart Failure Resilience Intervention for Caregivers

A study testing HEROIC in people with Heart Failure and Caregivers, run by Johns Hopkins University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Heart failure (HF) patients with supportive caregivers have better physical health, emotional health, and quality of life. But caregivers have an increased risk of caregivers' own worsening health and often feel a sense of burden related to caregiving. Read more about this study

Who is it for?
Ages 50 years and olderHealthy volunteers can take part
Conditions the study is for
Heart Failure, Caregivers
What is being tested?
HEROIC
Could I receive a placebo?
No, everyone receives an active treatment
How many people
33 participants
Where
1 siteUnited States
Study dates
1 Apr 2022to 31 Oct 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Aim 1 inclusion criteria:
  • Patients with a HF hospitalization in the last year and their informal caregivers (inclusion criteria below), nurse practitioners, physicians and members of the multidisciplinary team rounds will be included in focus groups.
  • Aim 2 \& 3 Inclusion:
  • Caregivers of patients served by the HF Bridge Clinic will be included if
  • the patient was hospitalized within 6 months
  • the caregiver agrees to work on goals that increase preventive health behaviors and/or decrease burden
  • caregivers live with the patient or visit them to provide care more than 3 times per week
  • the caregiver is 50 years or older and e) the caregiver is the spouse/partner or child of the patient.

Who cannot join

  • Caregivers who
  • themselves have a terminal diagnosis
  • or are cognitively impaired based on Mini-Mental State Examination (MMSE) screening will be excluded as response to the intervention may vary in these groups.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Johns Hopkins School of Nursing

    Baltimore, Maryland, 21205

Other trials in United States

About this study

Official title: Heart Failure Resilience Intervention for Caregivers (HEROIC)

Heart failure (HF) patients with supportive caregivers have better physical health, emotional health, and quality of life. But caregivers have an increased risk of caregivers' own worsening health and often feel a sense of burden related to caregiving. However, caregivers receive very little support to balance caring for the patient with caring for themselves. Therefore, this research will provide a program for caregivers of advanced heart failure patients to build on the caregiver's strengths, sense of purpose, and set goals for healthy lifestyle changes. The investigators believe that caregivers who receive the program will have better quality of life, less sense of burden, and a healthier lifestyle.

Read the detailed description

Aim 1) Develop the intervention through focus groups and human-centered design with key stakeholders with particular focus on race, gender and financial strain. Key stakeholders including patients, caregivers and healthcare providers will discuss prototypes and refine intervention components through human-centered design.

Aim 2) Refine intervention components through an open label pilot (N=5) of the intervention, followed by in-depth interviews. We will assess the salient features of the novel intervention components using mixed methods including examination of all quantitative measures and qualitative interviews to explore acceptability, participant/interventionist interactions, home environment factors, goal achievement and perceived value of intervention. Intervention components will be adapted for the trial based on results of aims 1 and 2.

Aim 3) Conduct a single-masked, waitlist control pilot trial of the HEROIC intervention (N=36). We hypothesize that caregivers who receive the intervention will show greater improvement in primary outcomes (preventive health behaviors, caregiver burden and QOL) and potential mechanisms (self-efficacy and biomarkers of resilience [interleukins 6 and 10]) than control caregivers.

Randomization: Caregivers will be randomized using a computer algorithm via REDCap to receive either: (1) intervention or (2) waitlist. Random assignment will be stratified by spousal vs non-spousal caregivers due to increased burden among non-spousal caregivers.

Waitlisted Control Group: The waitlisted group will receive usual care for caregivers for the first 16 weeks, which is normally limited to inclusion in some clinical assessment and teaching during patient visits. Waitlisted participants will receive monthly study postcards to encourage retention. After 16 weeks, they will begin the intervention.

Setting:

Aim 1: Key Stakeholder meetings will be held at the Johns Hopkins University School of Nursing, which is located within walking distance of the Heart Failure Bridge Clinic and supported by the Community Research Advisory Council.

Aims 2-3: Study visits will be conducted in the home of the caregiver.

Intervention Components

The intervention will be guided by the theory and evidence-based practices that have been successful in previous work. For the proposed study, every participant will receive each component of the intervention but interventionists will tailor content to each participant's goals. The investigators will focus on overall preventive health behaviors broadly categorized as physical activity, stress management, rest, healthy diet and appropriate healthcare utilization. As part of the intervention, the nurse and the caregiver will discuss preventive health categories. In this conversation, the caregiver will prioritize the preventive health categories that they would most like to address and then set goals towards them. Allowing the caregiver maximum control over this goal-setting, without placing additional burden on the caregiver is one aspect of increasing self-efficacy and person-centeredness. Because the intervention will allow participants to pick their own health goals, the investigators will measure goal attainment related to preventive health behaviors, rather than a standardized survey of predetermined preventive health behaviors.

Intervention Delivery/Study Visits

The intervention delivery characteristics will consist of an assessment-driven, tailored package of interventions delivered by a nurse interventionist. Nurse interventionists will be trained and equipped with education materials vetted by national organizations leading preventive health research such as the American Heart Association (Healthy for Good) and National Institute of Aging (Go4Life). The investigators propose an intervention incorporating 3 individualized, nurse-led, home-based sessions, with telephone check-ins and text reminders, according to participant preference. Baseline, 16 and 32-week data will be collected by interviewers masked to treatment assignment and without interventionist contact.

Interventional Protocol

The nurse will meet with the caregiver to perform the initial assessment in which the nurse will focus on preventive health behaviors and factors contributing to a sense of burden. To build rapport and model the importance of physical activity, the nurse will allow the caregiver to choose a short physical activity (ie. Walk around the block, 2 minutes of dancing etc). In this assessment, the nurse and the caregiver identify and prioritize goals, and make plans to achieve those goals. The nurse will provide the HEROIC Handbook, which will be developed following aim 1 and include evidence-based educational materials, contact information, and a calendar of sessions that the participant keeps for reference. In each session, the nurse assesses goal attainment, reinforces strategy use, reviews problem-solving, refines strategies (such as Go4Life physical activities and Healthy for Good materials), and provides education and resources to address future needs. Following the session, the nurse will find additional resources, tailored to each caregiver. In the final session, the nurse reviews the participants' strategies and helps to generalize them to other possible challenges or goals. Sessions will be spaced to encourage practicing new strategies independently after developing them together with the nurse. Although this intervention structure has been successful in work by the mentorship team, the investigators will adjust the timing and frequency of study visits based on feedback in phases 1 and 2. Bi-monthly meetings of the nurse with the site Research Coordinator and the principal investigator will ensure smooth communication, address challenges, supervision, and adherence to intervention fidelity.

Being tested
HEROIC
Keywords
Heart Failure, Caregivers, Resilience, Preventive Health Behaviors
Medical subject headings
Heart Failure

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HEROICBehavioural

    The HEROIC intervention will include individualized, nurse-led sessions focused on;

    1. a whole-person assessment including preventive health behaviors, personal goals, and purpose in life
    2. discussion of caregiving in the context of the caregiver's identified 'purpose' which supports meaning-making and provides rationale for goal-setting
    3. co-development of a plan to address caregiver goals to improve preventive health behaviors and/or reduce caregiver burden
    4. 'walking meetings' to model the importance of exercise while discussing incremental action plans to help caregivers achieve goals.
Study groups in NCT03963583
Study groupRoleWhat they receive
HEROIC Intervention GroupExperimentalThis group will receive the HEROIC intervention.
Receives: Behavioral: HEROIC
Waitlist Control GroupExperimentalThe waitlisted group will receive usual care for caregivers for the first 12 weeks, which is normally limited to inclusion in some clinical assessment and teaching during patient visits. Waitlisted participants will receive monthly study postcards to encourage retention. After 12 weeks, they will begin the intervention.
Receives: Behavioral: HEROIC

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Goal Attainment of Preventive Health Behaviors as Measured by the Goal Attainment Scale

    The Goal Attainment Scale is a self-reported attainment of goals implementing health-promoting behaviors, reported on a 5-point scale. Scores are converted to t-scores (0-100). 50 indicates the population mean with a standard deviation of 10. Higher scores indicate higher goal attainment.

    Measured: Baseline, 12 and 24 weeks

  2. Caregiver Burden as Assessed by the Oberst Caregiving Burden Scale

    Investigators will use the task difficulty and time caregiving subscales of the Oberst Caregiving Burden Scale. Both sub-scales include 15 likert scale items each. Scores range from 15-75 for the task difficulty and 15-75 for the time caregiving sub-scales. Higher scores indicate great task difficulty; higher scores indicate more time spent caregiving. Sub-scales are not combined in a total score.

    Measured: Baseline, 12 and 24 weeks

  3. Quality of Life as Assessed by the Neurological Quality of Life(Neuro-QOL)

    9-Item Neurological Quality of Life (Neuro-QOL). Items are scored on a 1-5 range, with total summary score calculated range of 9-45. Higher scores indicate a more favorable quality of life.

    Measured: Baseline, 12 and 24 weeks

Secondary outcomes (1)
  1. Self-Efficacy as Assessed by the Coping Self Efficacy Scale

    The coping self-efficacy scale has 13 items, each scored 0-10. Scores range from 0-130. Higher scores indicate higher coping self-efficacy.

    Measured: Baseline, 12 and 24 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2019
  2. Study start1 Apr 2022
  3. Primary completion31 Oct 2024
  4. Study completion31 Oct 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
33 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03963583
Sponsor's protocol ID
IRB00277814
Other IDs
1K12HD085845
Acronym
HEROIC
Status last verified
Nov 2025
First submitted
23 May 2019
Last updated
24 Nov 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Publications

  • Clair CA, Curriero SN, Saylor MA. Goal attainment scaling in the heart failure and stroke resilience caregiver intervention pilot study. J Patient Rep Outcomes. 2026 May 16;10(1):115. doi: 10.1186/s41687-026-01082-5.

    PubMed 42142302

Questions about this trial

What is this clinical trial studying?

A study testing HEROIC in people with Heart Failure and Caregivers, run by Johns Hopkins University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 24 Nov 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 24 Nov 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Goal Attainment of Preventive Health Behaviors as Measured by the Goal Attainment Scale (time frame: Baseline, 12 and 24 weeks). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03963583, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Nov 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in